• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Valeant Appoints Former Zoetis Exec as CFO


August 23, 2016

Valeant Pharmaceuticals International, Inc. (Laval, Quebec, Canada) announced that Paul S. Herendeen has been appointed Executive Vice President, Finance and will take over the role of Chief Financial Officer from Robert L. Rosiello, effective immediately.    Mr. Herendeen joins Valeant from animal health company Zoetis (Florham Park, NJ), where he served as Executive Vice President and CFO for the past two years. Mr. Rosiello will remain at Valeant as Executive Vice President, Corporate Development and Strategy.

Related Videos